FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bernhardt Zeiher

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Drug Dose Response Relationship

Disorders

Co-author Network

Publications

TOP 3
Lesley M Arnold; Birol Emir; T Kevin Murphy; Lynne Pauer; Gayle Scott; Bernhardt G Zeiher; Danielle Petersel
Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
Dona L Fleishaker; Juan A Garcia Meijide; James M Goodrich; Michael David Kohen; Howard B Mayer; Charles A Mebus; Sujatha Menon; Andriy Petrov; Thomas C Stock; Xin Wang; Bernhardt G Zeiher
Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial.
Bernhardt G Zeiher; Jay S Steingrub; Pierre-François Laterre; Alex Dmitrienko; Yonetaka Fukiishi; Edward Abraham
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bernhardt Zeiher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Lesley M Arnold; Birol Emir; T Kevin Murphy; Lynne Pauer; Gayle Scott; Bernhardt G Zeiher; Danielle Petersel
Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
Clinical therapeutics 2012;34(5):1092-102.
2012: Dona L Fleishaker; Juan A Garcia Meijide; James M Goodrich; Michael David Kohen; Howard B Mayer; Charles A Mebus; Sujatha Menon; Andriy Petrov; Thomas C Stock; Xin Wang; Bernhardt G Zeiher
Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial.
Arthritis research & therapy 2012;14(1):R11.
2005: Bernhardt G Zeiher; Jay S Steingrub; Pierre-François Laterre; Alex Dmitrienko; Yonetaka Fukiishi; Edward Abraham
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis.
Critical care medicine 2005;33(8):1741-8.
2005: David L Bowton; Alex Dmitrienko; Elliot Israel; Bernhardt G Zeiher; Gregory D Sides
Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma.
The Journal of asthma : official journal of the Association for the Care of Asthma 2005;42(1):65-71.
2004: Bernhardt G Zeiher; Antonio Artigas; Jean-Louis Vincent; Alex Dmitrienko; Kimberley Jackson; B Taylor Thompson; gordon bernard
Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study.
Critical care medicine 2004;32(8):1695-702.
2002: Bernhardt G Zeiher; Shozo Matsuoka; Kazuhito Kawabata; John Repine
Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics.
Critical care medicine 2002;30(5 Suppl):S281-7.